EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

SMARCB1 regulates the hypoxic stress response in sickle cell trait

Melinda Soeung iD, Luigi Perelli, Ziheng Chen, Eleonora Dondossola iD, I-Lin Ho iD, Federica Carbone iD, Li Zhang, Hania Khan, Courtney N Le iD, Cihui Zhu, Michael D Peoples iD, Ningping Feng und 17 weitere

Proceedings of the National Academy of Sciences · 23.05.2023 · 120 (21)

DOI: 10.1073/pnas.2209639120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 15.05.2023. Verfasst von Melinda Soeung und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77025. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Sickle Cell Trait. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, Translational Research Partnership, Division of Cancer Prevention, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal medullary carcinoma (RMC) is an aggressive kidney cancer that almost exclusively develops in individuals with sickle cell trait (SCT) and is always characterized by loss of the tumor suppressor SMARCB1 . Because renal ischemia induced by red blood cell sickling exacerbates chronic renal medullary hypoxia in vivo, we investigated whether the loss of SMARCB1 confers a survival advantage under the setting of SCT. Hypoxic stress, which naturally occurs within the renal medulla, is elevated under the setting of SCT. Our findings showed that hypoxia-induced SMARCB1 degradation protected renal cells from hypoxic stress. SMARCB1 wild-type renal tumors exhibited lower levels of SMARCB1 and more aggressive growth in mice harboring the SCT mutation in human hemoglobin A (HbA) than in control mice harboring wild-type human HbA. Consistent with established clinical observations, SMARCB1-null renal tumors were refractory to hypoxia-inducing therapeutic inhibition of angiogenesis. Further, reconstitution of SMARCB1 restored renal tumor sensitivity to hypoxic stress in vitro and in vivo. Together, our results demonstrate a physiological role for SMARCB1 degradation in response to hypoxic stress, connect the renal medullary hypoxia induced by SCT with an increased risk of SMARCB1-negative RMC, and shed light into the mechanisms mediating the resistance of SMARCB1-null renal tumors against angiogenesis inhibition therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsSickle Cell TraitAnimalsHumansMiceHypoxiaKidneySMARCB1 Protein

Stichwörter der Autor:innen

SMARCB1hypoxiarenal medullary carcinomasickle cell trait

Substanzen

SMARCB1 Protein

Autor:innen und Institutionen

  • Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77025.
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77025.
  • David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX 77025.
  • Nerviano Medical Sciences, Milan 20014, Italy.
  • Translational Research to Advance Therapeutics and Innovation in Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77025.
  • Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX 77025.

ORCID-Profile: Melinda Soeung, Eleonora Dondossola, I-Lin Ho, Federica Carbone, Courtney N Le, Michael D Peoples, Alessandro Carugo, Andrea Viale, Nizar M Tannir, Giulio F Draetta, Pavlos Msaouel

Förderung

  • NCI NIH HHS
  • Translational Research Partnership
  • Division of Cancer Prevention, National Cancer Institute

Zitieren

APA

Soeung, M., Perelli, L., Chen, Z., Dondossola, E., Ho, I. L., Carbone, F., Zhang, L., Khan, H., Le, C. N., Zhu, C., Peoples, M. D., Feng, N., Jiang, S., Zacharias, N. M., Minelli, R., Shapiro, D. D., Deem, A. K., Gao, S., Cheng, E. H., …, & Genovese, G. (2023). SMARCB1 regulates the hypoxic stress response in sickle cell trait. Proceedings of the National Academy of Sciences, 120(21). https://doi.org/10.1073/pnas.2209639120

Vancouver

Soeung M, Perelli L, Chen Z, Dondossola E, Ho IL, Carbone F, et al. SMARCB1 regulates the hypoxic stress response in sickle cell trait. Proceedings of the National Academy of Sciences. 2023;120(21). doi:10.1073/pnas.2209639120

BibTeX
@article{Soeung2023,
  author = {Soeung, Melinda and Perelli, Luigi and Chen, Ziheng and Dondossola, Eleonora and Ho, I-Lin and Carbone, Federica and Zhang, Li and Khan, Hania and Le, Courtney N and Zhu, Cihui and Peoples, Michael D and Feng, Ningping and Jiang, Shan and Zacharias, Niki Millward and Minelli, Rosalba and Shapiro, Daniel D and Deem, Angela K and Gao, Sisi and Cheng, Emily H and Lucchetti, Donatella and Walker, Cheryl L and Carugo, Alessandro and Giuliani, Virginia and Heffernan, Timothy P and Viale, Andrea and Tannir, Nizar M and Draetta, Giulio F and Msaouel, Pavlos and Genovese, Giannicola},
  title = {SMARCB1 regulates the hypoxic stress response in sickle cell trait},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  volume = {120},
  number = {21},
  doi = {10.1073/pnas.2209639120}
}
Kostenlos starten →